Global Bone Cancer Diagnosis and Therapeutics Market Research and Forecast 2018-2023

  • ID: 4471503
  • Report
  • Region: Global
  • Orion Market Research Private Limited
15 % OFF
until Jul 31st 2018
1 of 4

FEATURED COMPANIES

  • Ablynz
  • Amgen Inc.
  • Bayer AG
  • Debiopharma Group
  • F. Hoffmann-La Roche Ltd.
  • Infinity Pharmaceuticals
  • MORE
The global bone cancer diagnosis market is anticipated to grow at a CAGR of 7.8% by 2023. Several factors such as exposure towards radiation, factures, treatment for certain cancer related drugs, and genetic disorders cause bone cancer. Robust healthcare expenditure in developed countries, genetic disorder, and development of stem cell transplant technology are some of the major factors that drive the growth of the market. Rising geriatric population is one of the major factors that contribute to the growth of the market as several diseases rise with aging. The increase in the prevalence of the Paget diseases and others are the factors that are driving the market. Major symptoms of bone cancer include pain, swelling, and fractures. When the bone cancer develops in a bone, the bone weakens.

According to the Cancer Research UK organization, 580 new cases of bone sarcoma were found in the UK during 2014. The occurrence rate of bone sarcoma is anticipated to fall by 5% in the UK by 2035, to 1 case for each 100,000 individuals by 2035. 1 in every 1,140 men and 1 out of 1,660 women will be determined to have bone sarcoma amid their lifetime. The bone cancer diagnosis and therapeutics market has been segmented on the basis of type, therapies and end users. On the basis of type, the market has been segmented into primary bone cancer and secondary bone cancer. The primary bone cancer has been further bifurcated into osteosarcoma, chondrosarcoma, Ewing’s sarcoma, Spindle cell sarcoma, and chordoma. Based on diagnosis, the market has been bifurcated into MRI scan, X-rays, CT-scan, Radionuclide bones scans, biopsy and others. On the basis of therapies, the market has been bifurcated into radiation therapies, chemotherapy, cryosurgery, surgical treatment, targeted therapy and others. According to end user, the market has been segmented into multispecialty hospitals and cancer research centers.

Geographically, the worldwide bone cancer diagnosis and therapeutics showcase is divided into North America, Europe, Asia-Pacific, and Rest of the World. Asia Pacific market is considered to be the fastest growing market globally. The rise in number of cancer patients in the APAC region is considered to rise eventually enabling bone cancer diagnosis and therapeutics market to grow. North America and Europe are considered to be the dominating markets due to various factors such as high healthcare expenditure, development in technology, support from government, rising key market players fuel the growth of the market.

The key players in the bone cancer diagnosis and therapeutics market Include Ablynz, Allergan, Aveo pharmaceuticals, Inc., Amgen Inc., Amura Holdings Ltd., Bayer AG, Catena pharmaceuticals Inc., Celldex therapeutics, Debiopharma Group, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Galapagos NV, Infinity Pharmaceuticals, Medivir AB, Merrion Pharmaceuticals Plc., Novartis AG, Pfizer, Inc. These are the key strategic players of bone cancer diagnosis and therapeutics.

Market Segmentation:

Global bone cancer diagnosis and therapeutics market is segmented on the basis of, type, by therapies, by diagnosis, by end user and regional outlook.
  • Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, By Type
  • Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, By Therapies
  • Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, By Diagnosis
  • Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, By End User
  • Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, By Region
The Report covers:
  • Comprehensive research methodology of Global Bone cancer diagnosis and therapeutics
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Bone cancer diagnosis and therapeutics
  • Insights about market determinants which are stimulating the Global Bone cancer diagnosis and therapeutics
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Ablynz
  • Amgen Inc.
  • Bayer AG
  • Debiopharma Group
  • F. Hoffmann-La Roche Ltd.
  • Infinity Pharmaceuticals
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. by Segments
1.2.2. by Geography
1.2.3. by Stakeholders

2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of the World
2.4. Patent Analysis

3. Market Determinant
3.1. Motivators
3.1.1. Robust Healthcare Expenditure in the Developed Economies
3.1.2. Exposure Towards Radioactive Material
3.1.3. Rising Geriatric Population
3.1.4. Increasing Incidence of Paget Diseases Among Individuals
3.1.5. Stem Cell Transplants Technology
3.2. Restraints
3.2.1. Lack of Awarness Towards Diagnosis and Therapeutics in Developing and Under Develpoed Nations
3.2.2. High Cost of Treatment
3.3. Opportunities
3.3.1. R&D and Technological Advancement on the Treatment Technology

4. Market Segmentation
4.1. Global Bone Cancer Diagnosis and Therapeutics Market, by Type
4.1.1. Primary Bone Cancer
4.1.1.1. Osteosarcoma
4.1.1.2. Chondrosarcoma
4.1.1.3. Ewing's Sarcoma
4.1.1.4. Spindel Cell Sarcoma
4.1.1.5. Chordoma
4.1.2. Secondary Bone Cancer
4.2. Global Bone Cancer Diagnosis and Therapeutics Market, by Diagnosis
4.2.1. Mri Scans
4.2.2. X-Rays
4.2.3. Ct-Scan
4.2.4. Radionuclide Bone Sensors
4.2.5. Biopsy
4.2.6. Others
4.3. Global Bone Cancer Diagnosis and Therapeutics Market, by Therapies
4.3.1. Radiation Therapies
4.3.2. Chemotheraphy
4.3.3. Cryosurgery
4.3.4. Surgical Treatment
4.3.5. Targeted Theraphy
4.3.6. Others
4.4. Global Bone Cancer Diagnosis and Therapeutics Market, by End User
4.4.1. Multispeciality Hospitals
4.4.2. Cancer Research Centers

5. Competitive Landscape
5.1. Strategy Analysis
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.4. Rest of the World

7. Company Profiles
7.1. Ablynz
7.2. Allergan
7.3. Aveo Pharmaceuticals, Inc.
7.4. Amgen Inc.
7.5. Amura Holdings Ltd.
7.6. Bayer Ag
7.7. Catena Pharmaceuticals Inc.
7.8. Celldex Therapeutics
7.9. Debiopharma Group
7.10. Eli Lilly and Company
7.11. F. Hoffmann-La Roche Ltd.
7.12. Galapagos NV
7.13. Infinity Pharmaceuticals
7.14. Medivir Ab
7.15. Merrion Pharmaceuticals PLC.
7.16. Novartis Ag
7.17. Pfizer, Inc.

List of Tables:
Table 1 Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Geography, 2017-2023,
Table 2 Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($ Million)
Table 3 Global Primary Bone Cancer Market Research and Analysis, 2017-2023, ($ Million)
Table 4 Global Osteosarcoma Market Research and Analysis, 2017-2023, ($ Million)
Table 5 Global Chondrosarcoma Market Research and Analysis, 2017-2023, ($ Million)
Table 6 Global Ewing's Sarcoma Market Research and Analysis, 2017-2023, ($ Million)
Table 7 Global Spindle Cell Sarcoma Market Research and Analysis, 2017-2023, ($ Million)
Table 8 Global Chordoma Market Research and Analysis, 2017-2023, ($ Million)
Table 9 Global Secondary Bone Cancer Market Research and Analysis, 2017-2023, ($ Million)
Table 10 Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis, 2017-2023, ($ Million)
Table 11 Global Mri Scan Market Research and Analysis, 2017-2023, ($ Million)
Table 12 Global X-Rays Market Research and Analysis, 2017-2023, ($ Million)
Table 13 Global Ct-Scan Market Research and Analysis, 2017-2023, ($ Million)
Table 14 Global Radionuclide Bones Scans Market Research and Analysis, 2017-2023, ($ Million)
Table 15 Global Biopsy Market Research and Analysis, 2017-2023, ($ Million)
Table 16 Global Others Market Research and Analysis, 2017-2023, ($ Million)
Table 17 Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapies, 2017-2023, ($ Million)
Table 18 Global Radiation Therapy Market Research and Analysis, 2017-2023, ($ Million)
Table 19 Global Cryosurgery Market Research and Analysis, 2017-2023, ($ Million)
Table 20 Global Surgical Treatment Market Research and Analysis, 2017-2023, ($ Million)
Table 21 Global Targeted Therapy Market Research and Analysis, 2017-2023, ($ Million)
Table 22 Global Others Market Research and Analysis, 2017-2023, ($ Million)
Table 23 Global Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023, ($ Million)
Table 24 Global Multispecialty Hospitals Market Research and Analysis, 2017-2023, ($ Million)
Table 25 Global Cancer Research Institute Market Research and Analysis, 2017-2023, ($ Million)
Table 26 Merger and Acquisition
Table 27 Global Bone Cancer Diagnosis and Therapeutics Market, by Geography 2016-20122($ Million)
Table 28 North America Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 29 North America Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 30 North America Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapy 2017-2023($Million)
Table 31 North America Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)
Table 32 North America Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Countries 2017-2023($Million)
Table 33 Europe Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 34 Europe Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 35 Europe Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapy 2017-2023($Million)
Table 36 Europe Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)
Table 37 Europe Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Countries 2017-2023($Million)
Table 38 Asia Pacific Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 39 Asia Pacific Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 40 Asia Pacific Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapy 2017-2023($Million)
Table 41 Asia Pacific Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)
Table 42 Asia Pacific Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Countries 2017-2023($Million)
Table 43 Rest of the World Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 44 Rest of the World Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 45 Rest of the World Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapy 2017-2023($Million)
Table 46 Rest of the World Bone Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)

List of Figures:
Figure 1 Global Bone Cancer Diagnosis and Therapeutics Market Share, by Type 2017 and 2023, (In %)
Figure 2 Global Bone Cancer Diagnosis and Therapeutics Share, by Therapy 2017 and 2023, (In %)
Figure 3 Global Bone Cancer Diagnosis and Therapeutics Market Share, by Diagnosis 2017 and 2023, (In %)
Figure 4 Global Bone Cancer Diagnosis and Therapeutics Market Share, by End User 2017 and 2023, (In %)
Figure 5 Global Bone Cancer Diagnosis and Therapeutics Market Share, by Geography 2017 and 2023, (In %)
Figure 6 North American Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 7 US Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 8 Canada Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 9 European Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 10 UK Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 11 France Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 12 Germany Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 13 Italy Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 14 Spain Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 15 ROE Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 16 Asia Pacific Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 17 India Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 18 China Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 19 Japan Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 20 RoAPAC Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 21 Rest of the World Bone Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Ablynz
  • Allergan
  • Aveo Pharmaceuticals, Inc.
  • Amgen Inc.
  • Amura Holdings Ltd.
  • Bayer AG
  • Catena Pharmaceuticals Inc.
  • Celldex Therapeutics
  • Debiopharma Group
  • Eli Lilly And CoMPany
  • F. Hoffmann-La Roche Ltd.
  • Galapagos NV
  • Infinity Pharmaceuticals
  • Medivir AB
  • Merrion Pharmaceuticals Plc.
  • Novartis AG
  • Pfizer, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll